The University of Kansas School of Medicine is a public medical school located on the University of Kansas Medical Center campuses in Kansas City, Kansas, and also Salina, Kansas, and Wichita, Kansas.

During the past decade, University of Kansas School of Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas School of Medicine" #1 sponsor was "Bodyport Inc." with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Gala Therapeutics, Inc." with 1 trials sponsored and "Jaeb Center for Health Research" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas School of Medicine" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Icahn School of Medicine at Mount Sinai" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "University of Iowa" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas School of Medicine" are "Crohn's Disease" (2 trials), "Cervical Ripening" (1 trials), "Chronic Bronchitis" (1 trials), "Complex Perianal Fistula" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "University of Kansas School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Kansas School of Medicine" are "Drug" (5 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Sham Procedure" (2 trials), "Acetazolamide" (1 trials), "Bodyport Scale" (1 trials) and "Cx601" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas School of Medicine" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Kansas School of Medicine". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Kansas School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas School of Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".